Two cases of EGFR mutation-positive lung adenocarcinoma that transformed into squamous cell carcinoma: successful treatment of one case with rociletinib.
Department of Medical Oncology, Kinki University Faculty of Medicine, Osaka-Sayama.
K
K
Haratani
Department of Medical Oncology, Kinki University Faculty of Medicine, Osaka-Sayama hayashi_h@dotd.med.kindai.ac.jp.
H
H
Hayashi
Department of Medical Oncology, Kinki University Faculty of Medicine, Osaka-Sayama.
S
S
Watanabe
Department of Medical Oncology, Kinki University Faculty of Medicine, Osaka-Sayama Department of Medical Oncology, Kishiwada City Hospital, Kishiwada, Japan.
H
H
Kaneda
Department of Medical Oncology, Kinki University Faculty of Medicine, Osaka-Sayama.
T
T
Yoshida
Department of Medical Oncology, Kinki University Faculty of Medicine, Osaka-Sayama.
M
M
Takeda
Department of Medical Oncology, Kinki University Faculty of Medicine, Osaka-Sayama.
T
T
Shimizu
Department of Medical Oncology, Kinki University Faculty of Medicine, Osaka-Sayama.
K
K
Nakagawa
D000178:Acrylamides / Q000627:therapeutic use*; D000230:Adenocarcinoma / Q000175:diagnosis* / Q000188:drug therapy / Q000235:genetics; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002294:Carcinoma, Squamous Cell / Q000175:diagnosis* / Q000188:drug therapy / Q000235:genetics; D002471:Cell Transformation, Neoplastic; D066246:ErbB Receptors / Q000235:genetics*; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000175:diagnosis* / Q000188:drug therapy / Q000235:genetics; D008875:Middle Aged; D011743:Pyrimidines / Q000627:therapeutic use*; D016896:Treatment Outcome
D000178:Acrylamides; D000970:Antineoplastic Agents; D011743:Pyrimidines; C000589977:rociletinib; C512478:EGFR protein, human; D066246:ErbB Receptors